-
Former FDA Agent Says Big Pharma Not Likely To Get Involved In Cannabis Industry After Rescheduling
Friday, May 3, 2024 - 9:24am | 862Read More...Three national leaders gathered Wednesday to discuss the impact of the Drug Enforcement Administration's historic move to reclassify cannabis as a less dangerous drug. Removing marijuana from Schedule 1 – the same class as heroin, LSD, meth and ecstasy – to Schedule III along with...
-
Biden Considers Marijuana Rescheduling: Boon Or Bust For The Industry? Former Top FDA Official Weighs In
Tuesday, January 2, 2024 - 10:55am | 661Read More...Many observers agree that President Joe Biden's administration is poised for a historic shift in federal drug policy, that is loosening cannabis restrictions through potential rescheduling. But the move, while seemingly a step towards legalization, has sparked concerns from unexpected...
-
DEA Marijuana Rescheduling Likely By Next Year, Says Former FDA Official
Friday, November 10, 2023 - 3:33pm | 404Read More...A former Food and Drug Administration (FDA) official says he’d be "shocked" if the DEA does not reschedule cannabis by next year's presidential election, and that he expects the DEA will ultimately accept the recent Health and Human Services’ recommendation...
-
Could Marijuana Be A Schedule III Substance? Ex-FDA Official Thinks So
Monday, August 28, 2023 - 4:13pm | 638Read More...Marijuana could end up being categorized as a Schedule III substance under the Controlled Substances Act (CSA), reported Marijuana Moment, citing a former top Food and Drug Administration (FDA) official. How? Howard Sklamberg, who chaired the FDA's Marijuana Working Group from 2014 to 2017,...
